LENZ
LENZ Therapeutics
LENZ
LENZ
94 hedge funds and large institutions have $573M invested in LENZ Therapeutics in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.1% more ownership
Funds ownership: 68.13% → 72.23% (+4.1%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
94
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$22.2M | |
| 2 | +$10.8M | |
| 3 | +$6.51M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.92M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.3M |
Top Sellers
| 1 | -$8.23M | |
| 2 | -$6.39M | |
| 3 | -$3.31M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.55M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.34M |